Baidu
map

四川:药械集中采购制度实现降药价、防腐败等多重效果

2017-07-25 王文秋 澎湃新闻

“在药品采购方面,2016年底完成新一轮药品集中分类采购任务,3136个产品中标。”日前,四川省卫计委巡视员杜波在介绍四川省“五位一体”药械集中采购制度时公开表示,药品集中采购后,2016年四川省药品价格较上年同比下降10.59%,估计全省减少药费支出近40亿元。”作为全国最早推行药品器械集中采购的省份,2004年四川省就已经实现以省为单位的统一集中招标采购。2005年,四川省实行以省为单位的药品

“在药品采购方面,2016年底完成新一轮药品集中分类采购任务,3136个产品中标。”

日前,四川省卫计委巡视员杜波在介绍四川省“五位一体”药械集中采购制度时公开表示,药品集中采购后,2016年四川省药品价格较上年同比下降10.59%,估计全省减少药费支出近40亿元。”

作为全国最早推行药品器械集中采购的省份,2004年四川省就已经实现以省为单位的统一集中招标采购。2005年,四川省实行以省为单位的药品集中挂网限(竞)价,初步明确以政府为主导,以省(自治区、直辖市)为单位的网上药品集中招标采购发展方向。

所谓“五位一体”,即以建立健全规范、有序、高效的药品供应保障制度为核心,以信息化平台为载体,构建药品、医用耗材、医用设备、诊断试剂、二类疫苗“五位一体”集中采购新机制,加强医疗卫生机构药械采购使用行为监管。

杜波告诉记者,在药品方面,四川省的集中采购采用了多种手段保障价格和质量。

其中,对临床用量大、采购金额高、多家企业生产的药品,四川省药械集中采购服务中心按照带量采购要求,将2014年全省药品采购总金额前80%的品种纳入双信封招标采购范围。2017年2-4月,四川省分3批公布执行了1148个双信封招标中标药品,中标率31.99%,中标价格较上一年同比下降16.5%。

而对于部分专利药品、独家生产药品,四川则开展了谈判(议价)采购。两轮谈判后,中标价格较上一年同比下降7.66%,有1726个药品的中标价格达到或低于全国最低省级价。

杜波还表示,四川省还开展了价格预警管理。在四川省药采平台药械采购系统内,增设了医疗机构实际采购价格公示模块,公布每种药品的全省医疗机构当年年度最低采购价和平均采购价,并动态提示实际采购价格与公布价格的价差幅度,实时指导各级医疗机构议价采购。

针对药品耗材采购易出现腐败的问题,在医疗机构出现高值耗材异常采购行为时,四川省搭建的这一系统将发送采购价格异常电子预警书,对连续出现预警的机构,省卫计委将进行函询并要求限期整改,对整改不到位的纳入省级约谈范围,进一步强化预警效果。

记者从四川省卫计委获悉,去年以来,该省已对405家医疗机构发放高值耗材价格异常预警书1391份。

国家卫生计生委卫生发展研究中心药物政策研究室主任、研究员傅鸿鹏认为,四川省推行的药械集中采购,不是简单的物资采购,还具有规范医院物流管理预防腐败的政策功能。

傅鸿鹏表示,中国的药品集中采购,是伴随着行风建设和治理医药商业贿赂行动形成的,是多年的探索结果,具有强烈的监管意义。任何一个研究探索集中采购政策的人,不论是学者还是决策者,都不能忽视这样的背景和客观价值。中国的药品集中采购机构不仅仅是采购员、服务员,还是监督员和管理员。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1709662, encodeId=7d411e09662e0, content=<a href='/topic/show?id=f4bd853364c' target=_blank style='color:#2F92EE;'>#腐败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85336, encryptionId=f4bd853364c, topicName=腐败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce131763716, createdName=ms1490123962508630, createdTime=Thu Jul 27 04:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382894, encodeId=75dd138289433, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399417, encodeId=24d9139941e17, content=<a href='/topic/show?id=8bbe8e611a0' target=_blank style='color:#2F92EE;'>#药械#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87611, encryptionId=8bbe8e611a0, topicName=药械)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58f2204373, createdName=fengyqf, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460094, encodeId=3110146009420, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532706, encodeId=6b891532e06f7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1709662, encodeId=7d411e09662e0, content=<a href='/topic/show?id=f4bd853364c' target=_blank style='color:#2F92EE;'>#腐败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85336, encryptionId=f4bd853364c, topicName=腐败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce131763716, createdName=ms1490123962508630, createdTime=Thu Jul 27 04:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382894, encodeId=75dd138289433, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399417, encodeId=24d9139941e17, content=<a href='/topic/show?id=8bbe8e611a0' target=_blank style='color:#2F92EE;'>#药械#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87611, encryptionId=8bbe8e611a0, topicName=药械)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58f2204373, createdName=fengyqf, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460094, encodeId=3110146009420, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532706, encodeId=6b891532e06f7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=)]
    2017-07-27 wgx306
  3. [GetPortalCommentsPageByObjectIdResponse(id=1709662, encodeId=7d411e09662e0, content=<a href='/topic/show?id=f4bd853364c' target=_blank style='color:#2F92EE;'>#腐败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85336, encryptionId=f4bd853364c, topicName=腐败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce131763716, createdName=ms1490123962508630, createdTime=Thu Jul 27 04:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382894, encodeId=75dd138289433, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399417, encodeId=24d9139941e17, content=<a href='/topic/show?id=8bbe8e611a0' target=_blank style='color:#2F92EE;'>#药械#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87611, encryptionId=8bbe8e611a0, topicName=药械)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58f2204373, createdName=fengyqf, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460094, encodeId=3110146009420, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532706, encodeId=6b891532e06f7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=)]
    2017-07-27 fengyqf
  4. [GetPortalCommentsPageByObjectIdResponse(id=1709662, encodeId=7d411e09662e0, content=<a href='/topic/show?id=f4bd853364c' target=_blank style='color:#2F92EE;'>#腐败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85336, encryptionId=f4bd853364c, topicName=腐败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce131763716, createdName=ms1490123962508630, createdTime=Thu Jul 27 04:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382894, encodeId=75dd138289433, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399417, encodeId=24d9139941e17, content=<a href='/topic/show?id=8bbe8e611a0' target=_blank style='color:#2F92EE;'>#药械#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87611, encryptionId=8bbe8e611a0, topicName=药械)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58f2204373, createdName=fengyqf, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460094, encodeId=3110146009420, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532706, encodeId=6b891532e06f7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1709662, encodeId=7d411e09662e0, content=<a href='/topic/show?id=f4bd853364c' target=_blank style='color:#2F92EE;'>#腐败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85336, encryptionId=f4bd853364c, topicName=腐败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ce131763716, createdName=ms1490123962508630, createdTime=Thu Jul 27 04:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382894, encodeId=75dd138289433, content=<a href='/topic/show?id=99328e292cd' target=_blank style='color:#2F92EE;'>#药价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87292, encryptionId=99328e292cd, topicName=药价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399417, encodeId=24d9139941e17, content=<a href='/topic/show?id=8bbe8e611a0' target=_blank style='color:#2F92EE;'>#药械#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87611, encryptionId=8bbe8e611a0, topicName=药械)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58f2204373, createdName=fengyqf, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460094, encodeId=3110146009420, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532706, encodeId=6b891532e06f7, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Thu Jul 27 00:49:00 CST 2017, time=2017-07-27, status=1, ipAttribution=)]
    2017-07-27 wolongzxh

相关资讯

中央:深化药品医械审批改革

昨天(7月19日),中央深改组第37次会议召开,审议通过了《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》(以下简称《意见》)。        2015年8月,国务院曾经印发《关于改革药品医疗器械审评审批制度的意见》,标志着药品医疗器械审评审批制度改革的全面启动。        此项改革实施已有1年多,业内不

这4家医疗/医药企业被阿里列入售假黑名单

近日,阿里巴巴公布了100家淘宝售假企业“黑名单”,而在名单中,4家医药/医药类企业赫然“上榜”。

CFDA公告:8家械企产品抽检不符规定

5月8日,国家药监总局发布2017年第10期国家医疗器械质量公告。

还在用这些药?儿童十大用药禁区!

style="margin: 0px; padding: 0px; max-width: 100%; clear: both; min-height: 1em; box-sizing: border-box !important; word-wrap: break-word !important;">禁忌:苦楝皮临床已极少用于驱虫;使君子婴幼儿应慎用。原因:苦楝皮:有毒成分为川楝素和异川楝素。中毒

用药凹造型你会吗?(宝宝&成人篇)

宝宝篇宝宝用药的基础POSE:1、一个成人温和地约束宝宝,另一个成人喂药。2、用大毛巾裹住宝宝的胳膊和腿,将宝宝抱在膝盖上,把宝宝的两条腿夹在成人的两腿之间,一只手臂约束宝宝的身体,另一只手臂给宝宝喂药。口服药将宝宝的头部轻微后仰,轻轻压迫宝宝脸颊使口张开,用喂药器对准牙龈和脸颊之间,一次给予少量药物,注意不要给的太多太快。*泡腾片:大家都听过夺命泡腾片的新闻,不用害怕。按照下面的方法就能安全并优

从“肿瘤免疫疗法”发展历程,看“单抗、CAR-T”任重而道远!

近年来,随着肿瘤免疫调控机制的逐渐清晰和基因改造技术的不断提高,肿瘤免疫治疗领域得到了空前发展。从非特异性免疫刺激剂到肿瘤疫苗,再到针对免疫检查点阻断的单克隆抗体和过继细胞免疫治疗,一项项创新免疫治疗技术为人类抵抗肿瘤提供了更多的武器,也让那些屡战屡败的临床医生和科学家们重拾了信心。尤其是近5年,随着免疫检查点单抗药物与CAR-T细胞免疫治疗的崛起,免疫治疗的概念越来越深入

Baidu
map
Baidu
map
Baidu
map